Multiple phosphorylated tau (p-tau) isoforms—such as p-tau181, p-tau217, and p-tau 231—are characterized by distinct phosphorylation sites, each exhibiting unique clinical implications as blood-based biomarkers in AD and other neurodegenerative disorders [29]. Here, MAPT is linked to Alzheimer disease.